Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-26

FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Laurus Labs Limited)

View source ↗

Summary

FDA approved Laurus Labs Limited's generic emtricitabine and tenofovir disoproxil fumarate tablets under an Original Application (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Emtricitabine and Tenofovir Disoproxil Fumarate (emtricitabine and tenofovir disoproxil fumarate)

Snippet

ORIG AP for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)